Autophagy-Targeted Vascular Remodeling in Pulmonary Arterial Hypertension: Molecular Mechanisms and Therapeutic Perspectives
Journal of Cardiovascular Development and Disease · 13.08.2026 · 13 (8) · 387
DOI: 10.3390/jcdd13080387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 13.08.2026. Verfasst von Miao Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji 133000, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by progressively increased pulmonary vascular resistance and right heart failure. Its pathogenesis involves multiple factors, including genetic predisposition, inflammation, oxidative stress, and imbalances between cell proliferation and apoptosis. Recent studies indicate that autophagy has a context-dependent dual role in PAH. Flux-competent autophagy may be protective by clearing damaged mitochondria, limiting excessive inflammation, and maintaining metabolic homeostasis, whereas excessive autophagy initiation or impaired autophagosome-lysosome degradation may promote metabolic dysfunction, inflammatory signaling, abnormal vascular cell phenotypes, and pulmonary vascular remodeling. This focused narrative review summarizes the molecular mechanisms and key signaling pathways linking autophagy to PAH, with emphasis on PTEN-induced kinase 1 (PINK1)/Parkin-mediated mitophagy and the AMP-activated protein kinase (AMPK)/mechanistic target of rapamycin (mTOR) energy-sensing axis. It also evaluates potential therapeutic strategies targeting key nodes of autophagy, such as AMPK activators and mTOR inhibitors, along with their clinical research progress. Finally, this review provides an outlook on future research directions, emphasizing the need to further elucidate the dynamic regulatory mechanisms and cell-type specificity of autophagy in order to advance the clinical translation of autophagy-targeted precision therapies for PAH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Hypertension, Yanbian University Hospital, Yanji 133000, China.
- Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University, Yanji 133000, China.
ORCID-Profile: Miao Li, Limei Piao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, M., & Piao, L. (2026). Autophagy-Targeted Vascular Remodeling in Pulmonary Arterial Hypertension: Molecular Mechanisms and Therapeutic Perspectives. Journal of Cardiovascular Development and Disease, 13(8), 387. https://doi.org/10.3390/jcdd13080387
Vancouver
Li M, Piao L. Autophagy-Targeted Vascular Remodeling in Pulmonary Arterial Hypertension: Molecular Mechanisms and Therapeutic Perspectives. Journal of Cardiovascular Development and Disease. 2026;13(8):387. doi:10.3390/jcdd13080387
BibTeX
@article{Li2026,
author = {Li, Miao and Piao, Limei},
title = {Autophagy-Targeted Vascular Remodeling in Pulmonary Arterial Hypertension: Molecular Mechanisms and Therapeutic Perspectives},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {8},
pages = {387},
doi = {10.3390/jcdd13080387}
}
EUVIMED